About Von Willebrand Disease — What is VWD
The Humate-P® Difference: High Quality & Quantity
Home Infusion Video
Mix2Vial™ Needle-Free transfer Device

Mix2Vial™ Video
The CSL Behring Commitment
Resources and Tools
News & Events
Important Safety Information
Prescribing Information
Request More Information
For Healthcare Professionals
      

Let us walk you through the easy2use steps!

CSL Behring is pleased to offer Mix2VialTM—a Needle-Free device. Mix2VialTM is a simpler way to reconstitute products.

Let us walk you through the process of reconstituting product and filling a syringe using the Mix2VialTM Needle-free Transfer Device.

Before you start the reconstitution process, make sure you have everything you need, including alcohol swabs and disposable gloves.

Always wash your hands and make sure to use the disposable gloves.



Step 1:  Begin by removing the plastic caps from the two vials and wipe the top of each vial with an alcohol swab. Then, peel off the top of the Mix2VialTM package, but don’t take the device out yet!
 

Step 2:  Pick up the Mix2VialTM package and turn it upside down. Holding the sterile water vial with your other hand, push the blue tip into the top of the vial.
 

Step 3:  Now you can take the transfer device out of its package. Simply pull off the plastic and throw it away. Make sure you don’t touch the top of the device with the exposed tip.
 

Step 4:  Pick up the sterile water vial with the device attached and turn it upside down. Holding the product vial with your other hand, push the white tip into the top of the vial. Make sure it goes all the way in!
 

Step 5:  The sterile water will flow into the product vial automatically.
 

Step 6:  When the sterile water vial is empty, you can remove it from the product vial. Simply hold the product vial in
one hand and, using the other hand, turn the sterile
water vial counterclockwise until the two vials are disconnected.

If necessary, gently swirl the vial to make sure the product is completely dissolved.
 

Step 7:  Now you’re ready to fill the syringe. Pull the plunger back, insert the syringe and twist it clockwise into the Luer-Lok®. Push air from the syringe into the vial. Pick up the product vial containing the reconstituted solution and turn it upside down. Then draw the solution into the syringe.

If you do not get all of the mixed product out of the vial, try this technique--slowly rotate the vial to get the remaining product into the rubber stopper notch. This is important medicine, and you want to get the most from the vial.

When you have finished administering the product, make sure to discard the empty vials, transfer device, and syringe in a sharps container.


Important Safety Information

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized, Humate-P® is indicated in adult patients for treatment and prevention of bleeding in hemophilia A (classical hemophilia). Humate-P® is also indicated in adult and pediatric patients with von Willebrand disease (VWD) for (1) treatment of spontaneous and trauma-induced bleeding episodes, and (2) prevention of excessive bleeding during and after surgery. This applies to patients with severe VWD, and patients with mild and moderate VWD for whom use of desmopressin is known or suspected to be inadequate.

Humate-P® is contraindicated in individuals with a history of anaphylactic or severe systemic response to antihemophilic factor or von Willebrand factor preparations or to any of its components.

Thromboembolic events have been reported in VWD patients receiving coagulation factor replacement, especially in the setting of known risk factors for thrombosis. Caution should be exercised and antithrombotic measures considered.

Humate-P® is derived from human plasma. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Although few adverse reactions have been reported the most common are allergic-anaphylactic reactions, including urticaria, chest tightness, rash, pruritus, edema, shock, chills and fever, and hypervolemia. For patients undergoing surgery, the most common adverse reactions are postoperative wound or injection-site bleeding.

Please see accompanying full prescribing information for Humate-P®.